Elemental formula associated hypophosphataemic rickets.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
10 2019
Historique:
received: 21 05 2018
revised: 24 07 2018
accepted: 21 09 2018
pubmed: 14 10 2018
medline: 9 9 2020
entrez: 14 10 2018
Statut: ppublish

Résumé

Hypophosphataemic rickets (HR) is usually secondary to renal phosphate wasting but may occur secondary to reduced intake or absorption of phosphate. We describe a series of cases of HR associated with the use of Neocate A retrospective review of cases with HR associated with AAF use presenting to centres across the United Kingdom. 10 cases were identified, over a 9 month period, all associated with Neocate The presence of a normal TRP and resolution of hypophosphataemia and rickets following discontinuation of Neocate

Identifiants

pubmed: 30314926
pii: S0261-5614(18)32466-X
doi: 10.1016/j.clnu.2018.09.028
pii:
doi:

Substances chimiques

Amino Acids 0
Carbohydrates 0
Dietary Fats 0
Neocate 0
Phosphates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2246-2250

Informations de copyright

Crown Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Auteurs

S Uday (S)

Department of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham, UK; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

S Sakka (S)

Department of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham, UK.

J H Davies (JH)

Department of Endocrinology and Diabetes, University Hospital Southampton, Southampton, UK.

T Randell (T)

Department of Paediatric Endocrinology and Diabetes, Nottingham Children's Hospital, Nottingham, UK.

V Arya (V)

Department of Paediatric Endocrinology, Great Ormond Street Hospital, London, UK.

C Brain (C)

Department of Paediatric Endocrinology, Great Ormond Street Hospital, London, UK.

M Tighe (M)

Poole Hospital NHS Foundation Trust, Poole, UK.

J Allgrove (J)

Department of Paediatric Endocrinology, Great Ormond Street Hospital, London, UK.

P Arundel (P)

Department of Metabolic Bone Disease, Sheffield Children's Hospital, Sheffield, UK.

R Pryce (R)

Department of Paediatrics, Royal Gwent Hospital, Newport, UK.

W Högler (W)

Department of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham, UK; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

N J Shaw (NJ)

Department of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham, UK; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK. Electronic address: nick.shaw@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH